
Trump’s Pharma Tariffs Spark Industry Uncertainty, Experts Skeptical
Experts question Trump’s proposed drug tariffs, citing global supply chain complexities and high U.S. production costs. Industry investments may not lower prices or boost security.
News & Insights Across Asia
Experts question Trump’s proposed drug tariffs, citing global supply chain complexities and high U.S. production costs. Industry investments may not lower prices or boost security.
China reduces costs for advanced medical treatments through new pricing guidelines, making technologies like artificial hearts and cochlear implants more accessible.